Dakota Joshua will miss the start of training camp following surgery to remove a cancerous lump. The Vancouver Canucks forward hopes to play this season following an eventful summer.
A statement from Dakota Joshua: pic.twitter.com/7kaZV7Lw1Z
— Vancouver Canucks (@Canucks) September 17, 2024
Joshua Discovered a Lump, Prompting a Trip to the Doctor
In a statement released by the Canucks, Joshua explains how he visited the doctor after discovering a lump on his testicles. The forward was diagnosed with testicular cancer. Thankfully, the doctors were able to successfully remove the tumour.
Recovery is the Next Step
Joshua is now recovering from his surgery. However, it will cause him to miss the start of training camp and possibly longer. Following a cancer diagnosis and a surgery, missing some hockey is certainly a small price to pay for a possible clean bill of health.
When Joshua does return to the ice, he will be looking for an encore to his breakout season in the 2023-24 season. The forward scored 18 goals and 14 assists in 63 games for the Canucks last season. Furthermore, Joshua helped the Canucks through the Stanley Cup Playoffs, where they reached the second round. In late June, he signed a new four-year, $13-million deal to remain a Canuck.
Impact on the Canucks
Joshua’s successful treatments are welcome news to the Canucks organization. However, the time will come sooner rather than later where they will need to assess the roster to see who can fill in for Joshua. Joshua was originally projected to be play on the third line. The Canucks have options to fill the hole, including newcomer Danton Heinen, who is currently projected to be on the fourth line.
When Joshua returns to action, it will mean more than just a player returning from an injury. It will be an example of the wondrous works of medical technology and an example to all of us to embrace life, as we never know when a hip check is coming. As for Joshua, when he takes the ice once again, you can bet he will be taking in the moment.
Main Photo Credit: Bob Frid – USA TODAY Sports
